HCW Biologics (HCWB) Earnings Date & Reports

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

HCWB is expected to report earnings to fall 90.67% to -108 cents per share on November 12

HCW Biologics HCWB Stock Earnings Reports

Q3'26

Est.

$-1.08

Q2'26

Missed

by $10.38

Q1'26

Beat

by $17.82

Q4'25

Beat

by $1.41

Q3'25

Beat

by $0.28

The last earnings report on August 14 showed earnings per share of -1157 cents, missing the estimate of -120 cents. With 21.53K shares outstanding, the current market capitalization sits at 4.00M.

View a ticker or compare two or three

HCWB

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days